SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

COLACCI IRVING R

(Last)

(First)

(Middle)

POSSIS MEDICAL, INC.

9055 EVERGREEN BLVD NW

(Street)

MINNEAPOLIS

55433

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
POSSIS MEDICAL INC [ POSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Gen. Counsel and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2008

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/25/2008		U		3,542	D	$19.5	814	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$5.813							⁽¹⁾	09/14/2008	Common Stock	20,000		20,000	D
Stock Option (Right to Buy)	$8.625							⁽¹⁾	08/12/2009	Common Stock	30,000		30,000	D
Stock Option (Right to Buy)	$6.125							⁽¹⁾	08/07/2010	Common Stock	13,500		13,500	D
Stock Option (Right to Buy)	$6.125							⁽¹⁾	08/07/2010	Common Stock	26,500		26,500	D
Stock Option (Right to Buy)	$5.88							⁽¹⁾	11/02/2010	Common Stock	19,600		19,600	D
Stock Option (Right to Buy)	$3.9375							⁽¹⁾	04/03/2011	Common Stock	25,000		25,000	D
Stock Option (Right to Buy)	$12.1							⁽¹⁾	09/10/2012	Common Stock	22,000		22,000	D
Stock Option (Right to Buy)	$18.69							⁽¹⁾	08/28/2013	Common Stock	19,900		19,900	D
Stock Option (Right to Buy)	$17.25							⁽²⁾	09/17/2014	Common Stock	21,100		21,100	D
Stock Option (Right to Buy)	$12.57							⁽²⁾	08/29/2010	Common Stock	23,100		23,100	D
Stock Option (Right to Buy)	$8.66							⁽²⁾	08/15/2011	Common Stock	13,100		13,100	D
Stock Option (Right to Buy)	$10.19							⁽²⁾	08/08/2012	Common Stock	14,700		14,700	D

Explanation of Responses:

1. Currently fully vested.

2. In connection with the annoucement on February 11, 2008 by MEDRAD, Inc. that it will acquire 100% of the oustanding common shares of Possis Medical, Inc. at $19.50 per share through a tender offer, all outstanding stock options fully vested and become exercisable in their entirety on that date.

	Irving R. Colacci	03/27/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.